Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and II mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two related classes of eukaryotic zinc-containing HDACs have been recognized based upon sequence similarity: class I (HDAC1, 2, 3, and 8) and class II (HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al., 2002).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Gao et al., 2002
In the citing paper
“It has been shown to associate with HDAC6 (Gao et al., 2002; Cheng et al., 2014)”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Gao et al., 2002
In the citing paper
“HDAC11 is a newly identified member of the HDAC family and thus far no known physiological function for HDAC11 has been demonstrated23.”
From The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance (2009) · cites this paper as [23]
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Research works printed but not linked: 2
- Van Lint, 1996, Gene Expr., 5, 245
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
Cited by
Items 401–500 of 761
Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology
Staneva, R., Rukova, B. B., Hadjidekova, S. P., Nesheva, D. V., Antonova, O., Dimitrov, P. S., Simeonov, V., Stamenov, G., Čukuranoviç, R., Kokoris, J. Č., et al. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-225 · Cited by 22
“ticipate in other processes apart from strictly modulating chromatin composition [31].”
BackgroundTorres, O. V., Ladenheim, B., Jayanthi, S., McCoy, M. T., Krasnova, I. N., Vautier, F., & Cadet, J. L. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9591-3 · Cited by 23
“Given that HDAC11 also suppresses transcriptional activity (Sahakian et al. 2015; Gao et al. 2002), decreases in this enzyme, in addition to the decreased expression of other HDACs, might serve to potentiate METH-induced global changes in gene expression.”
Shirbhate, E., Patel, P., Patel, V. K., Veerasamy, R., Sharma, P. C., & Rajak, H. (2020) · Future Oncology · doi:10.2217/fon-2020-0385 · Cited by 25
Corticosterone-mediated regulation and functions of miR-218-5p in rat brain
Yoshino, Y., Roy, B., & Dwivedi, Y. (2022) · Scientific Reports · doi:10.1038/s41598-021-03863-y · Cited by 24
Cheng, C., Yun, F., He, J., Ullah, S., & Yuan, Q. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.017 · Cited by 21
Aizawa, S., Teramoto, K., & Yamamuro, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.024 · Cited by 24
“In addition, a new member of the HDAC amily, HDAC11, has recently been identified and classied as a new class IV HDAC owing to its distinct structure Gao et al., 2002).”
BackgroundZhao, N., Yang, F., Han, L., Qu, Y., Ge, D., & Zhang, H. (2020) · Molecules · doi:10.3390/molecules25030717 · Cited by 22
“Overexpression of HDACs have been found in different cancers [12,13], and histone deacetylase inhibitors (HDACis) have been shown to significantly suppress cell proliferation, angiogenesis and metastasis through multiple mechanisms [14,15].”
BackgroundVorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects
Sato, A. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s23874 · Cited by 22
“Vorinostat is a hydroxamic acid and has structure similar to that of trichostatin A, the first natural hydroxamate found to inhibit HDACs.”
InfluentialDesign and synthesis of novel hybrid benzamide–peptide histone deacetylase inhibitors
Hu, F., Chou, C. J., & Gottesfeld, J. M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.085 · Cited by 24
Lindberg, D. M., Åkerström, G., & Westin, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02694.x · Cited by 22
Parathyroid Hormone Regulates Histone Deacetylases in Osteoblasts
Shimizu, E., Selvamurugan, N., Westendorf, J. J., & Partridge, N. C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.037 · Cited by 23
Sadia, K., Castagna, A., Udali, S., Ambrosani, F., Pattini, P., Beri, R., Argentino, G., Masutti, M., Moruzzi, S., & Friso, S. (2025) · Cells · doi:10.3390/cells14171337 · Cited by 22
“In humans, the HDAC family characterization was last updated in 2002 with the discovery of HDAC11 [59].”
Epi-drugs as triple-negative breast cancer treatment
Idrissou, M., Sánchez, A., Penault-Llorca, F. M., Bignon, Y., & Bernard-Gallon, D. J. (2020) · Epigenomics · doi:10.2217/epi-2019-0312 · Cited by 23
An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma
GRAMMATIKAKI, S., Katifelis, H., Farooqı, A. A., STRAVODIMOS, K. G., Karamouzis, M. V., Souliotis, K. N., Varvaras, D., & Gazouli, M. (2023) · In Vivo · doi:10.21873/invivo.13049 · Cited by 25
“Gao et al. (52), were the first to identify and characterize the human HDAC11 and showed changes in its levels across normal and cancerous human tissues.”
BackgroundBaselious, F., Robaa, D., & Sippl, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107700 · Cited by 20
Gupta, P. K., Ho, P., Ha, S. G., Lin, Y.-W., & Wei, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004363 · Cited by 23
“Class I includes HDACs 1, 2, 3, 8, and possibly 11 [1,4].”
BackgroundHistone deacetylases in kidney development: implications for disease and therapy
Chen, S., & El-Dahr, S. S. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2223-8 · Cited by 20
Dynamic Expression of HDAC3 in db/db Mouse RGCs and Its Relationship with Apoptosis and Autophagy
Fu, Y., Wang, Y., Gao, X., Li, H., & Yuan, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6086780 · Cited by 20
“Class III is constituted of NAD-dependent sirtuins, including SIRTs 1, 2, 3, 4, 5, 6, and 7 [7, 8].”
BackgroundSalian‐Mehta, S., Xu, M., McKinsey, T. A., Tobet, S. A., & Wierman, M. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640482 · Cited by 24
“Earlier reports indicated that HDAC6 could interact with HDAC11, a class IV HDAC member, in both the cytoplasmic and nuclear compartments and act as a transcriptional activator for IL-10 (39).”
BackgroundAlterations of Histone Modifications in Cancer
Hosseini, A., & Minucci, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00006-6 · Cited by 33
Madsen, A. S., & Olsen, C. A. (2012) · Angewandte Chemie · doi:10.1002/ange.201203754 · Cited by 20
Inhibition of class I HDACs imprints adipogenesis toward oxidative and brown-like phenotype
Ferrari, A., Longo, R., Peri, C., Coppi, L., Caruso, D., Mai, A., Mitro, N., Fabiani, E. D., & Crestani, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158594 · Cited by 22
Small Molecule Modulators In Epigenetics: Implications in gene expression and therapeutics
Swaminathan, V., Reddy, B. A., Selvi, R. B., Sukanya, M. S., & Kundu, T. K. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_18 · Cited by 33
“(Gray and Ekstrom, 2001; Gao et al., 2002; Kao et al., 2002) All these enzymes possess a highly conserved catalytic domain of approximately 390 amino acids and appear to deacetylate their substrates by the same mechanism.”
BackgroundBiological function and small molecule inhibitors of histone deacetylase 11
Jia, G., Liu, J., Hou, X., Jiang, Y., & Li, X. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116634 · Cited by 20
Epigenetics of the failing heart
Marín-García, J., & Akhmedov, A. T. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9483-x · Cited by 22
A pan‐cancer analysis identifies HDAC11 as an immunological and prognostic biomarker
Li, R., Wu, X., Zhao, P., Xue, K., & Li, J. (2022) · The FASEB Journal · doi:10.1096/fj.202101742rr · Cited by 19
Koyuncuoğlu, T., Türkyılmaz, M., Gören, B., Çetınkaya, M., Cansev, M., & ALKAN, T. (2015) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-150549 · Cited by 20
“Class III, known as the sirtuins, are NAD+dependent enzymes (Haberland et al., 2009) and class IV includes HDAC11 as the sole member (Gao et al., 2002).”
Recent Prospectives of Anticancer Histone Deacetylase Inhibitors
Abbass, S. A., Hassan, H. A., Mohamed, M. F. A., Moustafa, G. A. I., & Abuo‐Rahma, G. E. A. (2019) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2019.14468.1051 · Cited by 24
The role of HDAC11 in obesity‐related metabolic disorders: A critical review
Yang, H., Chen, L., Sun, Q., Yao, F., Saeed, M., & Sun, C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30286 · Cited by 21
“…induction of IL‐10, changes in chromatin structure and the recruitment of transcription factors occur earlier, suggesting that there are other mechanisms involved in the regulation of IL‐10 expression by HDAC11, which may include the modification of some regulatory elements (Georgopoulos, 2009).”
BackgroundBoutillier, A., Rouaux, C., Panteleeva, I., & Loeffler, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_12 · Cited by 22
RhoB upregulation leads to either apoptosis or cytostasis through differential target selection
Marlow, L. A., Bok, I., Smallridge, R. C., & Copland, J. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0302 · Cited by 20
“Class IV have characteristics of both class I and class II HDACs with HDAC11 being its only member (Gao et al. 2002).”
BackgroundYang, M., Zhao, W., Zhang, J., Liu, L., Tian, S., Miao, Y., Jia, Y., Wang, L., Chai, Q., Wang, Q., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02550 · Cited by 18
The Role of Histone Deacetylases in Acute Lung Injury—Friend or Foe
Luo, G., Liu, B., Fu, T., Liu, Y., Li, B., Li, N., & Geng, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097876 · Cited by 21
“Class IV HDACs include only one member, HDAC11, which was discovered in 2002, and is mainly localized in the nucleus, it is highly expressed in the kidney, heart, brain, skeletal muscle, and testis [49].”
BackgroundHDAC-an important target for improving tumor radiotherapy resistance
Ling, R., Wang, J., Fang, Y., Yu, Y., Su, Y., Sun, W., Li, X., & Tang, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193637 · Cited by 22
“HDAC6/10 is mainly located in the cytoplasm, known as class IIb HDACs (18).”
BackgroundInfluentialChoi, H.-J., Kwon, S., & Kim, D. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.006 · Cited by 21
Flores, J., Takvorian, P. M., Weiss, L. M., Cali, A., & Gao, N. (2021) · Journal of Cell Science · doi:10.1242/jcs.253757 · Cited by 18
“Another transcription factor gene, histone deacetylase 11 (HDAC1) encodes a protein that is normally expressed in a tissue-specific manner and is found to be upregulated in several human cancer cell lines (Gao et al., 2002).”
BackgroundProliferative status regulates HDAC11 mRNA abundance in nontransformed fibroblasts
Bagui, T. K., Sharma, S. S., Ma, L., & Pledger, W. J. (2013) · Cell Cycle · doi:10.4161/cc.26433 · Cited by 18
“Identified in 2002, HDAC11 has a molecular mass of 39 kd, and in contrast to its ubiquitous relatives, is tissue-specific: it is expressed primarily in brain, heart, kidney, and skeletal muscle.(5) It is overexpressed in breast, colon, and other carcinoma cell lines, and its depletion induces apoptosis of tumor but no…”
BackgroundOverview of the Classical Histone Deacetylase Enzymes and Histone Deacetylase Inhibitors
Ververis, K., & Karagiannis, T. C. (2012) · ISRN Cell Biology · doi:10.5402/2012/130360 · Cited by 21
“An intense interest in function and pharmacological manipulation of these enzymes rapidly followed the initial cloning and characterization of the first human HDACs in the 1990s [15– 23].”
BackgroundTorres, O. V. (2022) · Genes · doi:10.3390/genes13050892 · Cited by 22
HDAC1 in axonal degeneration: A matter of subcellular localization
Kim, J. Y., & Casaccia, P. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12716 · Cited by 20
Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma
Zain, J. M. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.01.006 · Cited by 17
Budzyński, M. A., Crul, T., Himanen, S. V., Tóth, N., Ötvös, F., Sistonen, L., & Vígh, L. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0798-5 · Cited by 18
“We did not test HDAC11, a sole member of class IV, since its expression is limited to the muscle, brain, and kidney (Gao et al. 2002).”
The epigenetic alterations of human sperm cells caused by heroin use disorder
Nazmara, Z., Shirinbayan, P., Asgari, H. R., Ahadi, R., Asgari, F., Maki, C. B., Fattahi, F., Hosseini, B., Janzamin, E., & Koruji, M. (2020) · Andrologia · doi:10.1111/and.13799 · Cited by 21
Uba, A. İ., & Zengin, G. (2023) · Amino Acids · doi:10.1007/s00726-023-03297-y · Cited by 17
“HDAC11 is the only member of class IV HDAC, localized in the nucleus, and is mainly found in the brain, heart, kidneys, testis, and skeletal muscles (Gao et al. 2002).”
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Patil, R. S., Maloney, M. E., Lucas, R., Fulton, D. J., Patel, V. S., Bagi, Z. A., Kovács‐Kása, A., Kovács, L., Su, Y., & Verin, A. D. (2024) · Biomolecules · doi:10.3390/biom14020140 · Cited by 17
“HDAC11 is the most recently discovered zinc-dependent HDAC [182] and the only member of class IV HDACs with some unique features (listed in Figure 2).”
BackgroundCheng, F., Zheng, B., Wang, J., Zhao, G., Yao, Z., Niu, Z., & He, W. (2021) · Cancer Medicine · doi:10.1002/cam4.4156 · Cited by 19
New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer
Chiaradonna, F., Cirulli, C., Palorini, R., Votta, G., & Alberghina, L. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5854 · Cited by 19
“Class IV comprises only HDAC11, which is localized in the nucleus and is not found to reside in any of the known HDAC complexes (49).”
Growth attenuation is associated with histone deacetylase 10-induced autophagy in the liver
Pinto, G., Shtaif, B., Phillip, M., & Gat‐Yablonski, G. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.031 · Cited by 17
“Anti-HDAC1,HDAC6andHDAC10were obtained fromAbcam(Cambridge,MA,USA); anti-HDAC10 was obtained also from Biovision (Milpitas, CA, USA); anti-HDAC4 and antimicrotubule-associated protein light chain LC3 were from Cell Signaling (Danvers, MA, USA); anti-HDAC5, HDAC7, HDAC8 and HDAC11 as well as anti-SQSTM1/P62 and anti-Hs…”
Ramaiah, M. J., Naushad, S. M., Lavanya, A., Chatla, S., Devi, T. A., Sampathkumar, S., Dharan, D. B., & Bhadra, M. P. (2017) · Gene · doi:10.1016/j.gene.2017.06.031 · Cited by 18
Khatun, S., Bhagat, R. P., Dutta, R., Datta, A., Jaiswal, A., Halder, S., Jha, T., Amin, S. A., & Gayen, S. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116312 · Cited by 17
Jain, R., & Epstein, J. A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_18 · Cited by 18
Rationale for HDAC Inhibitor Therapy in Autoimmunity and Transplantation
Hancock, W. W. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_6 · Cited by 16
Singh, P., Suzuki, T., Mandal, T., Balsubramanian, N., Haldar, M., Mueller, D. J., Strode, J. A., Cook, G. R., Mallik, S., & Srivastava, D. K. (2014) · Biochemistry · doi:10.1021/bi500711x · Cited by 16
Histone deacetylases and cardiovascular cell lineage commitment
Yang, J., Wang, Q., Wang, W., & Zeng, L.-F. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.852 · Cited by 16
Singh, P., Lall, N., Leedahl, T. S., McGillivray, A., Mandal, T., Haldar, M., Mallik, S., Cook, G. R., & Srivastava, D. K. (2013) · Biochemistry · doi:10.1021/bi400740x · Cited by 17
Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents
Cheng, J., Qin, J.-H., Guo, S., Qiu, H., & Zhong, Y. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.080 · Cited by 15
Assays for pharmacodynamic analysis of histone deacetylase inhibitors
Chung, E. J., Lee, M.-J., Lee, S., & Trepel, J. B. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.2.213 · Cited by 16
“Heltweg and colleagues published a nonisotopic assay that can be used for assay of the class I and II HDACs and the class III sirtuins [65], as well as a report of subtype selective substrates for HDACs [66].”
BackgroundInfluentialHistone deacetylase inhibitors: a survey of recent patents
Weinmann, H., & Ottow, E. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.12.1677 · Cited by 16
“HDAC11 is a another member of the HDAC enzymes that was recently cloned and characterised [17].”
BackgroundA narrative review of the role of HDAC6 in idiopathic pulmonary fibrosis
Yu, H., Liu, S., Wang, S., & Gu, X. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1183 · Cited by 16
“Class II HDACs include HDAC 4, 5, 6, 7, 9, and 10, which are similar in sequence to the yeast HDAC1 protein and are expressed in both the cytoplasm and nucleus (9) .”
Singh, P. K., Tomar, R. S., & Rath, S. K. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3881-y · Cited by 15
Chapter 21 Recent Advances in the Medicinal Chemistry of Histone Deacetylase Inhibitors
Brittain, D. E. A., Weinmann, H., & Ottow, E. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42021-8 · Cited by 14
Histone deacetylase 5 represses the transcription of cyclin D3
Roy, S., Shor, A. C., Bagui, T. K., Seto, E., & Pledger, W. J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21771 · Cited by 14
“Another HDAC, HDAC11, shares homology with both class I and class II HDACs [Gao et al., 2002].”
BackgroundBaselious, F., Hilscher, S., Hagemann, S., Tripathee, S., Robaa, D., Barinka, C., Hüttelmaier, S., Schutkowski, M., & Sippl, W. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400486 · Cited by 16
HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry
Rajaraman, S., Balakrishnan, R., Deshmukh, D., Ganorkar, A., Biswas, S., Pulya, S., & Ghosh, B. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0054 · Cited by 16
N-Acetylaspartate Drives Oligodendroglial Differentiation via Histone Deacetylase Activation
Dominicis, A., Giovane, A. D., Torreggiani, M., Recchia, A. D., Ciccarone, F., Ciriolo, M. R., & Ragnini‐Wilson, A. (2023) · Cells · doi:10.3390/cells12141861 · Cited by 16
“We focused on HDAC1, HDAC6, HDAC11, SIRT1, and SIRT2, which have been directly related to OL differentiation in humans [43] and mice [31,37,43–47].”
BackgroundRole of Histone Deacetylase and Inhibitors in Cardiovascular Diseases
Zhang, L., Wang, Y., Wen, R., Zhang, T., & Yang, N. (2025) · Cell Proliferation · doi:10.1111/cpr.70077 · Cited by 13
A Class II Histone Deacetylase Acts on Newly Synthesized Histones in Tetrahymena
Smith, J. J., Torigoe, S. E., Maxson, J. E., Fish, L., & Wiley, E. A. (2008) · Eukaryotic Cell · doi:10.1128/ec.00409-07 · Cited by 15
5 Histone Deacetylase Inhibitors: A Novel Class of Anti-Cancer Agents on its Way to the Market
Körner, M., & Tibes, U. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00005-7 · Cited by 13
Gray, S. G., Iglesias, A. H., Teh, B. T., & Dangond, F. (2003) · Gene Expression · doi:10.3727/000000003783992342 · Cited by 14
Bai, P., Mondal, P., Liu, Y., Gomm, A., Suen, C., Yang, L., Zhu, B., Sun, H., Ran, C., Shen, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14616 · Cited by 17
Huang, P.-Y., Shih, I.-A., Liao, Y., You, H., & Lee, M. (2022) · PubMed · Cited by 16
Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis
Cheng, H., Jiang, S.-H., Cai, J., Luo, Z., Li, X., & Feng, D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1426508 · Cited by 15
“HDAC11 has 347 amino acids and similar sequences to the catalytic core regions of Class I and II HDAC proteins (Gao et al., 2002; Thangapandian et al., 2012).”
BackgroundDiscovery of De Novo Macrocycle Inhibitors of Histone Deacetylase 11
Danková, D., Nielsen, A. L., Zarda, A., Hansen, T. N., Hesse, M., Benová, M., Tsiris, A., Bartling, C. R. O., Will, E. J., Strømgaard, K., et al. (2025) · JACS Au · doi:10.1021/jacsau.4c01148 · Cited by 14
Xu, Y., Fan, S., Liu, Y., Shi, J., Xie, X., Wang, X., Wang, C., Liu, X., & Xia, G. (2022) · Biology · doi:10.3390/biology11101464 · Cited by 14
Histone deacetylase inhibitors merged with protein tyrosine kinase inhibitors
Zhou, N., Xu, W., & Zhang, Y. (2015) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2015.01001 · Cited by 12
“Class IV HDAC (HDAC11) is comprised of a unique member HDAC11 just because of the specific structure of HDAC11 (4).”
BackgroundHistone deacetylase inhibitors in multiple myeloma
Deleu, S., Menu, E., Valckenborgh, E. V., Camp, B. V., Fraczek, J., Broek, I. V., Rogiers, V., & Vanderkerken, K. (2009) · Hematology Reports · doi:10.4081/hr.2009.e9 · Cited by 12
“HDAC11 represents class IV and contains residues in the catalytic core regions similar to both class I and II enzymes but does not have strong enough identity to be placed in either class.(34)”
BackgroundZhang, Y., Wenwen, L., Wang, K., & Jian, S. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.07.01 · Cited by 13
Bonomi, R. E., Girgenti, M. J., Krystal, J. H., & Cosgrove, K. (2022) · Complex Psychiatry · doi:10.1159/000524079 · Cited by 17
Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
Antrobus, J., & Parsons, J. L. (2022) · Radiation · doi:10.3390/radiation2010011 · Cited by 11
Schioppa, T., Nguyen, H. O., Tiberio, L., Sozio, F., Gaudenzi, C., Passari, M., Prete, A. D., Bosisio, D., & Salvi, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179752 · Cited by 14
“Class IV HDACs comprise one single member, namely, HDAC11, possessing a catalytic site similar to both class I and II HDACs, but not strong enough to be classified into any of these two categories [6].”
BackgroundZhao, H., Zhang, X.-M., Xiao, S., Wu, Z., Shi, Y., & Xie, M.-J. (2023) · PubMed Central · Cited by 15
Lim, W., Hwang, I., Zhang, J., Chen, Z., Han, J., Jeon, J., Koo, B., Kim, S., Lee, J. E., Kim, Y., et al. (2023) · eLife · doi:10.7554/elife.88830 · Cited by 17
“HDACs have been an attractive therapeutic strategy for restoring both acetylation and ( I ) Representative images show the expression of NUPR1 ( Gao et al., 2002 ) and HDAC11 ( Liedtke et al., 2008 ) on a TNBC TMA with different tumor grades (grades 1, 2, and 3).”
BackgroundSystemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells
Nam (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000224 · Cited by 11
Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins
Engel, J. A., Norris, E. L., Gilson, P. R., Przyborski, J. M., Shonhai, A., Blatch, G. L., Skinner‐Adams, T. S., Gorman, J. J., Headlam, M. J., & Andrews, K. T. (2019) · Experimental Parasitology · doi:10.1016/j.exppara.2019.01.008 · Cited by 14
Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents
Mohapatra, T. K., Nayak, R. R., Ganeshpurkar, A., Tiwari, P. K., & Kumar, D. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010006 · Cited by 11
Kwon, H., Ahn, S., Park, S. H., Park, J., Park, J. W., Kim, H. M., Park, S., Lee, K., Lee, C., Choi, E., et al. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1723 · Cited by 11
Therapeutic Approaches to Histone Reprogramming in Retinal Degeneration
Berner, A., & Kleinman, M. E. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_6 · Cited by 13
“There is only one Class IV HDAC (HDAC11) which is also zinc dependent, localized to the nucleus and is heavily conserved in all living eukaryotes other than fungi (Gao et al. 2002).”
BackgroundFunctional Analysis of Histone Deacetylase 11 (HDAC11)
Chen, J., Sahakian, E., Powers, J. J., Lienlaf, M., Perez-Villarroel, P., Knox, T. J., & Villagra, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_11 · Cited by 12
“HDAC11 was discovered in 2002 [6], and because of its shared characteristic with class I and class II HDACs it was classified in a new and independent group known as class IV HDACs, where it is the only member.”
BackgroundFan, C., & Huang, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.051 · Cited by 11
Class I histone deacetylases in retinal progenitors and differentiating ganglion cells
Saha, A., Tiwari, S., Dharmarajan, S., Otteson, D. C., & Belecky‐Adams, T. L. (2018) · Gene Expression Patterns · doi:10.1016/j.gep.2018.08.007 · Cited by 12
Polsinelli, G. A., & Yu, H. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204538 · Cited by 15
Athira, K. V., Wahul, A. B., Soren, K., Das, T., Dey, S. K., Samudrala, P. K., Kumar, A., Lahkar, M., & Chakravarty, S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105083 · Cited by 11
Chen, J., Cheng, F., Sahakian, E., Powers, J. J., Wang, Z., Tao, J., Seto, E., Pinilla-Ibarz, J. A., & Sotomayor, E. M. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1a1119-606rrr · Cited by 12
Александрович, Ю. П., Aleksandrova, Y. R., & Неганова, М. Е. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178629 · Cited by 16
“For example, the HDAC6 isoform is expressed predominantly in the heart, brain, skeletal muscles, and skin, the HDAC10 isoform is expressed in the liver, and the HDAC11 isoform is expressed in smooth muscles, heart, kidneys, and brain tissue [17,18].”
Human neuronal cells: epigenetic aspects
Kukucka, J., Wyllie, T., Read, J. L., Mahoney, L., & Suphioglu, C. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2012-0053 · Cited by 11
“HDAC11, the most recently characterized HDAC, is the only member of class 4, due to its differing phylogeny (41) , and is shown to be the most abundant HDAC in the rat brain (42) .”
Histone deacetylases in vascular permeability and remodeling associated with acute lung injury
Kovács, L., Kovács‐Kása, A., Verin, A. D., Fulton, D. J., Lucas, R., & Su, Y. (2018) · Vessel Plus · doi:10.20517/2574-1209.2018.06 · Cited by 10
“It contains a catalytic domain at the N-terminus and short N- and C-terminal extensions([36]).”
HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
Sriramareddy, S. N., Faião‐Flores, F., Emmons, M. F., Saha, B., Chellappan, S., Wyatt, C. J., Smalley, I., Licht, J. D., Durante, M. A., Harbour, J. W., et al. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00452-7 · Cited by 11
“HDAC11 is the smallest known HDAC (39 kDa) and is the sole type IV HDAC (31).”
Roles of HDACs in the Responses of Innate Immune Cells and as Targets in Inflammatory Diseases
Hu, Y., & Suliman, B. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_4 · Cited by 12
Histone modification and regulation of chromatin function
Koryakov, D. E. (2006) · Russian Journal of Genetics · doi:10.1134/s1022795406090043 · Cited by 13
The involvement of HDAC3 in the pathogenesis of lung injury and pulmonary fibrosis
Yu, H., Liu, S., Wang, S., & Gu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1392145 · Cited by 11
Metadata
- Authors
- Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Atadja, Peter
- ORCID
- Gao, Lin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 277
- Issue
- 28
- Pages
- 25748-25755
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070089404
- Cited by
- 744
- References
- 43
- Citations by year
- 2026: 27 · 2025: 28 · 2024: 32 · 2023: 36 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 30 · 2017: 36 · 2016: 30 · 2015: 41 · 2014: 34 · 2013: 30 · 2012: 37
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC11, histone deacetylase, cDNA cloning, histone deacetylase activity, tissue expression, nuclear localization, protein complexes, evolutionary conservation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cloning, Molecular, Histone Deacetylases, Humans, Molecular Sequence Data, Nuclear Proteins, RNA, Messenger, Sequence Homology, Amino Acid, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.